Llorente L, Bellido V, Pérez Cuadrado S
Rev Esp Oncol. 1984;31(1):27-33.
The RST-SAS effect in normal adult albino New Zealand giant male rabbits was studied. A positive individual response in 89% of the animal and no harmful side-effects were observed, after the i.v. administration of a suitable RSTL-SAS dose. The statistical evaluation of group data showed a significative 42% increased of the IIC.PHA above the normal basal level. Thus, the RSTL-SAS could provide an unique immunomodulator agent due to its significant biological effect and the apparent lack of any side effect.
研究了正常成年雄性新西兰白化巨兔的RST - SAS效应。静脉注射适当剂量的RSTL - SAS后，89%的动物出现阳性个体反应，且未观察到有害副作用。对组数据的统计评估显示，IIC.PHA比正常基础水平显著增加了42%。因此，RSTL - SAS因其显著的生物学效应和明显缺乏任何副作用，可能成为一种独特的免疫调节剂。
